Circular 8 of 2025 – Call For Submission of Applications for Registration Of Human Allopathic Medicines Through the Expedited Review Pathway: Phase I of 2025

3 days ago

The Medicines Control Authority of Zimbabwe (MCAZ), in its capacity as the ZAZIBONA Implementing Agency, successfully coordinated the 3rd ZAZIBONA Quality Circle alongside fellow ZAZIBONA Member Agencies, including SAHPRA, BOMRA, ZAMRA, NMRC, among others. The Quality Circle was held from 8–9 December 2025.This year’s session brought together 120 industry experts from across the SADC and EAC regions, demonstrating a shared commitment to regulatory harmonization and advancing pharmaceutical quality within the region.Key technical topics covered included:1. Technology transfer2. Transport validation3. HVAC system qualification4. Microbiology testing of water5. Common deficiencies in sterile manufacturing facilities6. Common deficiencies in general oral solid dosage formsMCAZ noted with appreciation the strong participation from Zimbabwean pharmaceutical manufacturers and technical professionals. This level of engagement reflects the country’s continued commitment to strengthening innovation, compliance with regulatory standards, and enhancement of technical capacity within the local pharmaceutical sector. Such collaboration aligns with national priorities and directly supports the National Development Strategy 2 (NDS2) objective of improving equitable access to quality-assured health products for all Zimbabweans.Through these coordinated regional efforts, MCAZ and its ZAZIBONA counterparts continue to advance regulatory systems, promote capacity building within the pharmaceutical industry, and contribute to a more resilient and healthier SADC region. ... See MoreSee Less

Photo

View on Facebook

Medicines Control Authority of Zimbabwe

5 days ago

📢 The Medicines Control Authority of Zimbabwe (MCAZ) has published its Client Service Charter, now available on the Authority’s official website.The Charter outlines MCAZ’s service standards, key commitments, turnaround times, and the rights and responsibilities of its clients. This publication reflects the Authority’s ongoing dedication to transparency, accountability, and high-quality regulatory service delivery.👉 The Charter can be accessed on www.mcaz.co.zw/wp-content/uploads/2025/11/2025-client-service-charter.pdf MCAZ remains committed to safeguarding public health through efficient, predictable, and customer-focused regulatory processes. ... See MoreSee Less

Photo

View on Facebook

Medicines Control Authority of Zimbabwe

2 weeks ago

Substandard and falsified (SF) medicines threaten millions of people worldwide.Report to the MCAZ, any suspected SF products you may encounter. The Authority urges the public to access registered medicines from licenced persons and premises. #medsafety ... See MoreSee Less

Photo

View on Facebook

Medicines Control Authority of Zimbabwe

2 weeks ago

Today, the Authority joins the global community in commemorating #WorldAIDSDay Day 2025.MCAZ reaffirm its commitment to protecting public health by ensuring access to safe, effective, and good-quality medicines and medical devices.Last month, the Authority approved and registered #lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to help prevent HIV-1 infection—supporting national and global efforts in the fight against HIV and AIDS.Together, we can strengthen the response, save lives, and build a healthier future.#WorldAIDSDay ... See MoreSee Less

Photo

View on Facebook

Circular 8 of 2025 – Call For Submission of Applications for Registration Of Human Allopathic Medicines Through the Expedited Review Pathway: Phase I of 2025

QUICK LINKS

FACEBOOK FEED

X FEED

CONTACT US